Can analysts adopt a bullish outlook for Medifast Inc (NYSE:MED)?

September 13, 2017 - By Nellie Frank

 Can analysts adopt a bullish outlook for Medifast Inc (NYSE:MED)?
Investors sentiment decreased to 1.11 in Q4 2016. Its down 0.30, from 1.41 in 2016Q3. It dropped, as 12 investors sold Medifast Inc shares while 53 reduced holdings. 19 funds opened positions while 53 raised stakes. 10.30 million shares or 1.41% more from 10.16 million shares in 2016Q3 were reported.
Wells Fargo And Communication Mn owns 83,975 shares. First Citizens Bank Trust holds 8,341 shares or 0.04% of its portfolio. Hl Services Llc has invested 0.01% in Medifast Inc (NYSE:MED). Matarin Cap Ltd Limited Liability Company has 91,587 shares for 0% of their portfolio. Swiss Retail Bank stated it has 14,600 shares or 0% of all its holdings. Clarivest Asset Management Limited Liability Co stated it has 0.09% of its portfolio in Medifast Inc (NYSE:MED). Schwab Charles Investment Mngmt Inc, a California-based fund reported 40,520 shares. Chicago Equity Partners Limited Liability Corporation accumulated 17,320 shares. First Quadrant L P Ca has 44,265 shares. Public Employees Retirement Association Of Colorado invested in 0% or 8,334 shares. Enterprise Fincl Corporation reported 0% stake. Gsa Ptnrs Llp invested in 96,904 shares. Blackrock reported 41,882 shares. State Board Of Administration Of Florida Retirement has 12,083 shares for 0% of their portfolio. Chickasaw Management Ltd Liability reported 0.05% in Medifast Inc (NYSE:MED).

Medifast Inc (NYSE:MED) Ratings Coverage

Among 3 analysts covering Medifast (NYSE:MED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Medifast had 6 analyst reports since August 10, 2015 according to SRatingsIntel. As per Monday, October 5, the company rating was upgraded by Sidoti. The firm has “Buy” rating given on Wednesday, August 16 by DA Davidson. Zacks downgraded Medifast Inc (NYSE:MED) on Monday, August 10 to “Hold” rating. The rating was downgraded by Sidoti to “Neutral” on Monday, November 30. Wunderlich initiated the stock with “Hold” rating in Friday, January 29 report. The firm earned “Buy” rating on Monday, January 11 by Sidoti. Below is a list of Medifast Inc (NYSE:MED) latest ratings and price target changes.

16/08/2017 Broker: DA Davidson Rating: Buy New Target: $65.0 Initiate

About 38,909 shares traded. Medifast Inc (NYSE:MED) has risen 25.81% since September 13, 2016 and is uptrending. It has outperformed by 9.11% the S&P500.

Medifast, Inc. is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. The company has market cap of $652.82 million. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins. It has a 27.47 P/E ratio. The Firm provides weight loss, weight management and healthy living products and programs through multiple channels of distribution, which include Take Shape For Life; its direct to consumer business unit through its Website and in-house call centers; Franchise Medifast Weight Control Centers, and a national network of physicians.

More important recent Medifast Inc (NYSE:MED) news were published by: Prnewswire.com which released: “Medifast, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results” on March 09, 2017, also Prnewswire.com published article titled: “Medifast, Inc. Announces First Quarter 2017 Financial Results”, Prnewswire.com published: “Medifast, Inc. Announces Second Quarter 2017 Financial Results” on August 08, 2017. More interesting news about Medifast Inc (NYSE:MED) was released by: Seekingalpha.com and their article: “Medifast Is Overweight With Inventory. Will Margins Slim Down?” with publication date: June 01, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.